|
2024 Journal Article Improving clinical efficiency using retrieval‐augmented generation in urologic oncology: A guideline‐enhanced artificial intelligence approachCollin, Harry, Roberts, Matthew J., Keogh, Kandice, Siriwardana, Amila and Basto, Marnique (2024). Improving clinical efficiency using retrieval‐augmented generation in urologic oncology: A guideline‐enhanced artificial intelligence approach. BJUI Compass, 6 (1) e427, e427. doi: 10.1002/bco2.427 |
|
2024 Journal Article A pilot study of PSMA PET/CT and MRI fusion for prostate cancer: Software to replace PET/MRI hardwareMehawed, Georges, Roberts, Matthew J., Bugeja, Jessica, Dowling, Jason, Stewart, Kate, Gunasena, Rivindi, Malczewski, Frances, Rukin, Nicholas J. and Murray, Rebecca (2024). A pilot study of PSMA PET/CT and MRI fusion for prostate cancer: Software to replace PET/MRI hardware. Journal of Clinical Medicine, 13 (23) 7384, 1-11. doi: 10.3390/jcm13237384 |
|
2024 Journal Article Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristicsRoberts, Matthew J., Papa, Nathan, Veerman, Hans, de Bie, Katelijne, Morton, Andrew, Franklin, Anthony, Raveenthiran, Sheliyan, Yaxley, William J., Donswijk, Maarten L., van der Poel, Henk G., Samaratunga, Hemamali, Wong, David, Brown, Nicholas, Parkinson, Robert, Gianduzzo, Troy, Kua, Boon, Coughlin, Geoffrey D., Oprea‐Lager, Daniela E., Emmett, Louise, van Leeuwen, Pim J., Yaxley, John W. and Vis, André N. (2024). Prediction of biochemical recurrence after radical prostatectomy from primary tumour characteristics. BJU International, 134 (S2), 47-55. doi: 10.1111/bju.16482 |
|
2024 Conference Publication The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriersTeppala, S., Scuffham, P., Edmunds, K., Roberts, M., Fairbairn, D., Smith, D., Horvath, L. and Tuffaha, H. (2024). The cost-effectiveness of germline BRCA testing in prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. ISPOR Europe 2024: Generating Evidence Toward Health and Well-Being, Barcelona, Spain, 17-20 November 2024. New York, United States: Elsevier. doi: 10.1016/j.jval.2024.10.610 |
|
2024 Conference Publication The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriersTeppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew, Fairbairn, David, Smith, David, Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of targeted germline BRCA testing in localised prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. COSA's 51st Annual Scientific Meeting Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD Australia, 13–15 November 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Journal Article The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriersTeppala, Srinivas, Scuffham, Paul, Edmunds, Kim, Roberts, Matthew J., Fairbairn, David, Smith, David P., Horvath, Lisa and Tuffaha, Haitham (2024). The cost-effectiveness of germline BRCA testing in metastatic prostate cancer followed by cascade testing of first-degree relatives of mutation carriers. Value in Health, 27 (11), 1515-1527. doi: 10.1016/j.jval.2024.06.019 |
|
2024 Journal Article The role of prostate-specific membrane antigen positron emission tomography/computed tomography in primary staging of selected renal tumours: initial experience in a multicentre cohortTariq, Arsalan, Pearce, Adam, Rhee, Handoo, Kyle, Samuel, Raveenthiran, Sheliyan, Pelecanos, Anita, Gan, Chun Loo, Goh, Jeffrey C., Wong, David, McBean, Rhiannon, Marsh, Phillip, Goodman, Steven, Dunglison, Nigel, Esler, Rachel, Navaratnam, Anojan, Yaxley, John W., Thomas, Paul, Pattison, David A. and Roberts, Matthew J. (2024). The role of prostate-specific membrane antigen positron emission tomography/computed tomography in primary staging of selected renal tumours: initial experience in a multicentre cohort. European Urology Focus, 10 (5), 770-778. doi: 10.1016/j.euf.2023.12.004 |
|
2024 Journal Article Cost-utility analysis of navigate, a treatment decision aid for men with prostate cancer and their partners, in comparison to usual careLindsay, Daniel, Schofield, Penelope, Roberts, Matthew J., Yaxley, John, Quinn, Stephen, Richards, Natalie, Frydenberg, Mark, Gardiner, Robert, Lawrentschuk, Nathan, Juraskova, Ilona, Murphy, Declan G. and Collins, Louisa G. (2024). Cost-utility analysis of navigate, a treatment decision aid for men with prostate cancer and their partners, in comparison to usual care. European Urology Oncology, 8 (3), 674-680. doi: 10.1016/j.euo.2024.08.005 |
|
2024 Journal Article Beyond prostate imaging reporting and data system: combining magnetic resonance imaging prostate imaging reporting and data system and prostate-specific membrane antigen-positron emission tomography/computed tomography primary score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancerEmmett, Louise, Papa, Nathan, Hope, Thomas A., Fendler, Wolfgang, Calais, Jeremie, Burger, Irene, Eiber, Matthias, Barbato, Francesco, Moon, Daniel, Counter, William, John, Nikeith, Xue, Alan, Franklin, Anthony, Thompson, James, Rasiah, Kris, Frydenberg, Mark, Yaxley, John, Buteau, James, Agrawal, Shikha, Ho, Bao, Nguyen, Andrew, Liu, Victor, Lee, Jonathan, Woo, Henry, Hsiao, Edward, Sutherland, Thomas, Perry, Elyse, Stricker, Phillip, Hofman, Michael S. ... Murphy, Declan (2024). Beyond prostate imaging reporting and data system: combining magnetic resonance imaging prostate imaging reporting and data system and prostate-specific membrane antigen-positron emission tomography/computed tomography primary score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer. The Journal of Urology, 212 (2), 299-309. doi: 10.1097/JU.0000000000004010 |
|
2024 Journal Article EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: screening, diagnosis, and local treatment with curative intentCornford, Philip, van den Bergh, Roderick C.N., Briers, Erik, Van den Broeck, Thomas, Brunckhorst, Oliver, Darraugh, Julie, Eberli, Daniel, De Meerleer, Gert, De Santis, Maria, Farolfi, Andrea, Gandaglia, Giorgio, Gillessen, Silke, Grivas, Nikolaos, Henry, Ann M., Lardas, Michael, van Leenders, Geert J.L.H., Liew, Matthew, Linares Espinos, Estefania, Oldenburg, Jan, van Oort, Inge M., Oprea-Lager, Daniela E., Ploussard, Guillaume, Roberts, Matthew J., Rouvière, Olivier, Schoots, Ivo G., Schouten, Natasha, Smith, Emma J., Stranne, Johan, Wiegel, Thomas ... Tilki, Derya (2024). EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: screening, diagnosis, and local treatment with curative intent. European Urology, 86 (2), 148-163. doi: 10.1016/j.eururo.2024.03.027 |
|
2024 Journal Article ChatGPT can help guide and empower patients after prostate cancer diagnosisCollin, Harry, Keogh, Kandice, Basto, Marnique, Loeb, Stacy and Roberts, Matthew J. (2024). ChatGPT can help guide and empower patients after prostate cancer diagnosis. Prostate Cancer and Prostatic Diseases, 28 (2) 87, 513-515. doi: 10.1038/s41391-024-00864-6 |
|
2024 Journal Article Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancerButeau, James P., Moon, Daniel, Fahey, Michael T., Roberts, Matthew J., Thompson, James, Murphy, Declan G., Papa, Nathan, Mitchell, Catherine, De Abreu Lourenco, Richard, Dhillon, Haryana M., Kasivisvanathan, Veeru, Francis, Roslyn J., Stricker, Phillip, Agrawal, Shihka, O'Brien, Jonathan, McVey, Aoife, Sharma, Gaurav, Levy, Sidney, Ayati, Narjess, Nguyen, Andrew, Lee, Su-Faye, Pattison, David A., Sivaratnam, Dinesh, Frydenberg, Mark, Du, Yang, Titus, Jehan, Lee, Sze-Ting, Ischia, Joseph, Jack, Greg ... Emmett, Louise (2024). Clinical trial protocol for PRIMARY2: a multicentre, phase 3, randomised controlled trial investigating the additive diagnostic value of [68Ga]Ga-PSMA-11 positron emission tomography/computed tomography in men with negative or equivocal multiparametric magnetic resonance imaging for the diagnosis of clinically significant prostate cancer. European Urology Oncology, 7 (3), 544-552. doi: 10.1016/j.euo.2023.11.008 |
|
2024 Journal Article Determining the optimal fill volume for fluid‐filled testicular prostheses – less is moreMehawed, Georges, Murray, Rebecca, Wang, Kevin, Roberts, Matthew J. and Rukin, Nicholas J. (2024). Determining the optimal fill volume for fluid‐filled testicular prostheses – less is more. BJU International, 134 (S2), 14-16. doi: 10.1111/bju.16374 |
|
2024 Journal Article What to do about recurrent urinary tract infections: A review of evidence behind emerging therapiesWynn, Jessica, Homewood, David, Tse, Vincent, Fong, Eva, Roberts, Matthew J., Chung, Eric and Dowling, Caroline (2024). What to do about recurrent urinary tract infections: A review of evidence behind emerging therapies. Australian Journal of General Practice, 53 (5), 265-273. doi: 10.31128/AJGP-10-23-7004 |
|
2024 Journal Article Prostate tumour visualisation with PET: is image fusion with MRI the answer?Mehawed, Georges, Murray, Rebecca, Rukin, Nicholas J. and Roberts, Matthew J. (2024). Prostate tumour visualisation with PET: is image fusion with MRI the answer?. BJU International, 133 (Supplement 4), 4-6. doi: 10.1111/bju.16335 |
|
2024 Journal Article Exploring unmet needs in prostate cancer care: a cross-sectional descriptive studyRoberts, Natasha A., Esler, Rachel, Pearce, Adam, Wyld, David, Smith, Michael, Woollett, Kaylene, Mazariego, Carolyn and Roberts, Matthew J. (2024). Exploring unmet needs in prostate cancer care: a cross-sectional descriptive study. European Urology Open Science, 62, 36-42. doi: 10.1016/j.euros.2024.01.018 |
|
2024 Journal Article Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?Roberts, Matthew J., Yaxley, John W., Stranne, Johan, van Oort, Inge M. and Tilki, Derya (2024). Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?. Prostate Cancer and Prostatic Diseases, 28 (2) e430466, 1-3. doi: 10.1038/s41391-024-00821-3 |
|
2024 Journal Article Cancer‐on‐chip and integrative tumor microenvironment sensor technologies for progressing precision radiotherapyDey, Shuvashis, Kinoshita, Masaki, Puttick, Simon, Rose, Stephen, Trau, Matt, Roberts, Matthew J. and Koo, Kevin M. (2024). Cancer‐on‐chip and integrative tumor microenvironment sensor technologies for progressing precision radiotherapy. Advanced Sensor Research, 3 (7) 2300193. doi: 10.1002/adsr.202300193 |
|
2024 Conference Publication Early oncological outcomes following radical prostatectomy of patients with pelvic lymph node-positive prostate cancer at preoperative PSMA PET/CTZuur, L.G., de Bie, K., Vis, A.N., Van Der Poel, H.G., Donswijk, M.L., Oprea-Lager, D.E., Roberts, M. and Van Leeuwen, P.J. (2024). Early oncological outcomes following radical prostatectomy of patients with pelvic lymph node-positive prostate cancer at preoperative PSMA PET/CT. EAU24 - 39th Annual EAU Congress, Paris, France, 5-8 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(24)01187-4 |
|
2024 Conference Publication Combining MRI PI-RADS and PSMA-PET/CT PRIMARY score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancerEmmett, L., Papa, N., Hope, T., Fendler, W., Calais, J., Burger, I., Eiber, M., Barbato, F., Moon, D., Xue, A., Franklin, A., Thompson, J., Rasiah, K., Frydenberg, M., Yaxley, J., Buteau, J., Liu, V., Nguyen, A., Hsiao, E., Stricker, P., Hofman, M., Kasivisvanathan, V., Roberts, M. and Murphy, D. (2024). Combining MRI PI-RADS and PSMA-PET/CT PRIMARY score in a composite (P) score for more accurate diagnosis of clinically significant prostate cancer. EAU24 - 39th Annual EAU Congress, Paris, France, 5-8 April 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0302-2838(24)00417-2 |
